http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3389132
Outgoing Links
Predicate | Object |
---|---|
contentType | Journal Article |
endingPage | 28 |
issn | 1948-5875 |
issueIdentifier | 1 |
pageRange | 27-28 |
publicationName | ACS Medicinal Chemistry Letters |
startingPage | 27 |
bibliographicCitation | Sabnis RW. Novel Macrocyclic Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors. ACS Med. Chem. Lett. 2022 Jan 03;13(1):27–8. doi: 10.1021/acsmedchemlett.1c00689. |
creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7289-0581 |
date | 2022-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier | https://doi.org/10.1021/acsmedchemlett.1c00689 https://pubmed.ncbi.nlm.nih.gov/35059120 https://pubmed.ncbi.nlm.nih.gov/PMC8762737 |
isPartOf | https://portal.issn.org/resource/ISSN/1948-5875 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
language | English |
source | https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title | Novel Macrocyclic Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors |
Incoming Links
Total number of triples: 26.